☆ 4.7 Article

Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA

TRANSLATIONAL RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Detecting Liver Cancer Using Cell-Free DNA Fragmentomes

Zachariah H. Foda et al.

Summary: Liver cancer is a major cause of cancer mortality worldwide and current screening methods are inadequate. The study used whole-genome cell-free DNA fragmentome analyses to evaluate individuals with hepatocellular carcinoma (HCC) and developed a machine learning model that showed high sensitivity and specificity in detecting cancer.

CANCER DISCOVERY (2023)

添加到收藏夹

Review Oncology

Cell-free DNA analysis in current cancer clinical trials: a review

M. Cisneros-Villanueva et al.

Summary: Cell-free DNA analysis is a promising method for the diagnosis and treatment selection of cancer patients. Despite the need for standardization and technical validation, numerous clinical trials have shown its potential in early cancer detection and treatment improvement.

BRITISH JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Oncology

The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples

Ruben Van Paemel et al.

Summary: There is a good agreement between DNA copy number alterations (CNAs) in tissue DNA and circulating cell-free DNA (cfDNA) obtained from liquid biopsies. The quality of cfDNA sample can affect the concordance between tissue DNA and cfDNA CNAs. Liquid biopsies can provide complementary analysis to tissue biopsies, as both cfDNA and tissue DNA can contain CNAs that cannot be identified in the other biomaterial.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell-free DNA fragmentomics

Xiangyu Zhang et al.

Summary: This study aims to develop an accurate and affordable method for the early detection of primary liver cancer (PLC) and differentiating between its subtypes using plasma cell-free DNA (cfDNA) fragmentomic profiles, showing excellent clinical potential.

HEPATOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Saife N. Lone et al.

Summary: Liquid biopsies are non-invasive methods that have revolutionized cancer diagnosis and monitoring. By analyzing tumor-derived entities in body fluids, liquid biopsies provide detailed information about tumor characteristics and can be used for detection, prognosis, and treatment monitoring.

MOLECULAR CANCER (2022)

添加到收藏夹

Review Oncology

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

Blanca Trujillo et al.

Summary: Liquid biopsy is a powerful tool for detecting cancer aberrations in real-time, especially in prostate cancer. However, there are still challenges in screening, risk stratification, and treatment of advanced disease. Therefore, developing better biomarkers is urgently needed to guide oncologists' decisions.

BRITISH JOURNAL OF CANCER (2022)

添加到收藏夹

Review Oncology

Circulating tumour DNA - looking beyond the blood

Ann Tivey et al.

Summary: Over the past decade, liquid biopsy techniques have emerged as alternatives to traditional tissue biopsy samples. Majority of research in this field has focused on blood-based biomarkers, especially circulating tumor DNA (ctDNA) derived from plasma. However, ctDNA can also be obtained from non-blood sources such as urine, cerebrospinal fluid, and pleural or peritoneal fluid. In this review, the authors discuss the advances in analyzing ctDNA from non-blood sources, exploring the distinct advantages and technical aspects of non-blood ctDNA assay development. They also reflect on when non-blood ctDNA can have advantages over plasma ctDNA and the challenges of translating these assays into clinical use.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling

Wei Guo et al.

Summary: A predictive model based on cfDNA fragmentomics was developed for early-stage lung adenocarcinoma (LUAD) detection. The model showed high sensitivity for early lesions and small-sized tumors and remained effective even with reduced sequencing depth.

EBIOMEDICINE (2022)

添加到收藏夹

Review Medical Laboratory Technology

Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management

Blake Salfer et al.

Summary: Urine cell-free DNA liquid biopsy provides a non-invasive method for cancer detection, which may replace or supplement tissue/blood biopsies. Studies have shown that the use of urine cell-free DNA can sensitively detect mutations and other biomarkers for various types of cancer.

CLINICAL CHEMISTRY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA

Jonathan C. M. Wan et al.

Summary: This study investigates mutational signatures in plasma whole genome sequencing and uses machine learning to distinguish cancer patients from healthy individuals, potentially enabling early cancer detection and assessment of cancer risk and etiology.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Oncology

cfDNA methylome profiling for detection and subtyping of small cell lung cancers

Francesca Chemi et al.

Summary: This article describes a workflow for genome-wide DNA methylation profiling that can be used to detect circulating cell-free DNA in patients with small cell lung cancer, and is correlated with survival outcomes. Additionally, this method can also differentiate between different SCLC subtypes.

NATURE CANCER (2022)

添加到收藏夹

Article Medicine, General & Internal

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon et al.

Summary: The long-term follow-up of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) did not show a significant reduction in deaths due to ovarian or tubal cancer with screening. While there was an increase in early-stage cancer detection in the MMS group, it did not translate into lives saved, highlighting the importance of specifying cancer mortality as the primary outcome in screening trials. Consequently, general population screening for ovarian and tubal cancer cannot be recommended.

LANCET (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Women's cancers in China: a spatio-temporal epidemiology analysis

Rongxin He et al.

Summary: The study found that in China, the incidence and mortality of breast cancer showed a slow upward trend, while cervical cancer had a dramatic increase in incidence and ovarian cancer had a fast increasing trend in mortality. Significant differences were detected in the incidence and mortality of breast, cervical, and ovarian cancer across east, central, and west China.

BMC WOMENS HEALTH (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A novel decision tree model based on chromosome imbalances in cell-free DNA and CA-125 in the differential diagnosis of ovarian cancer

Weina Zhang et al.

Summary: The study developed a novel hybrid model, OCDT, integrating genetic variations from cell-free DNA and CA-125 to effectively differentiate malignant from benign ovarian tumors, demonstrating improved detection accuracy.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2021)

添加到收藏夹

Article Biology

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours

Sally M. Hunter et al.

BMC RESEARCH NOTES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Genome-wide cell-free DNA fragmentation in patients with cancer

Stephen Cristiano et al.

NATURE (2019)

添加到收藏夹

Article Oncology

Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis

Yanting Zhang et al.

BMC CANCER (2019)

添加到收藏夹

Article Oncology

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer

Daniel G. Stover et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

添加到收藏夹

Article Genetics & Heredity

Copy number signatures and mutational processes in ovarian carcinoma

Geoff Macintyre et al.

NATURE GENETICS (2018)

添加到收藏夹

Article Oncology

Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses

Adriaan Vanderstichele et al.

CLINICAL CANCER RESEARCH (2017)

添加到收藏夹

Article Oncology

Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling

Youn Jin Choi et al.

JOURNAL OF PATHOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

Jennifer Ducie et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Review Oncology

Variant Review with the Integrative Genomics Viewer

James T. Robinson et al.

CANCER RESEARCH (2017)

添加到收藏夹

Article Genetics & Heredity

Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue

Tanjina Kader et al.

GENOME MEDICINE (2016)

添加到收藏夹

Article Oncology

Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma

Oumou Goundiam et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

添加到收藏夹

Article Medicine, General & Internal

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis

Roland F. Schwarz et al.

PLOS MEDICINE (2015)

添加到收藏夹

Article Biochemical Research Methods

Phylogenetic Quantification of Intra-tumour Heterogeneity

Roland F. Schwarz et al.

PLOS COMPUTATIONAL BIOLOGY (2014)

添加到收藏夹

Article Biochemical Research Methods

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

Helga Thorvaldsdottir et al.

BRIEFINGS IN BIOINFORMATICS (2013)

添加到收藏夹

Review Pathology

Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review

Simona Ferraro et al.

JOURNAL OF CLINICAL PATHOLOGY (2013)

添加到收藏夹

Article Oncology

Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma

Chang Ohk Sung et al.

CANCER GENETICS (2013)

添加到收藏夹

Article Oncology

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Zhigang C. Wang et al.

CLINICAL CANCER RESEARCH (2012)

添加到收藏夹

Article Oncology

Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations

Sally M. Hunter et al.

CLINICAL CANCER RESEARCH (2012)

添加到收藏夹

Article Oncology

Genomic aberrations relate early and advanced stage ovarian cancer

Afra Zaal et al.

CELLULAR ONCOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial

Saundra S. Buys et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

添加到收藏夹

Letter Biotechnology & Applied Microbiology

Integrative genomics viewer

James T. Robinson et al.

NATURE BIOTECHNOLOGY (2011)

添加到收藏夹

Article Biotechnology & Applied Microbiology

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Craig H. Mermel et al.

GENOME BIOLOGY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim et al.

NATURE (2010)

添加到收藏夹

Review Oncology

Ovarian cancer: the duplicity of CA125 measurement

Amer K. Karam et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis

Manasa Ramakrishna et al.

PLOS ONE (2010)

添加到收藏夹

Article Biochemical Research Methods

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

Gabriela Bindea et al.

BIOINFORMATICS (2009)

添加到收藏夹

Article Oncology

A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

Samuel C. Mok et al.

CANCER CELL (2009)

添加到收藏夹

Article Oncology

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

Dariush Etemadmoghadam et al.

CLINICAL CANCER RESEARCH (2009)

添加到收藏夹

Article Oncology

DNA profiling of primary serous ovarian and Fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification

M. E. Nowee et al.

JOURNAL OF PATHOLOGY (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.